-
Diagnostics World News | At the Bio-IT World Conference & Expo last month, several sessions explored ways AI is transforming oncology diagnosis, research, and care delivery. Speakers from the National Cancer Institute, Tempus Labs, The Ohio State University, IQVIA, Pangaea Data, University of Illinois Cancer Center, Stable Solutions and more discussed how far we’ve come, and where our next challenges lie.
Jun 7, 2022
-
Diagnostics World News | The U.S. Food and Drug Administration’s Center for Devices and Radiological Health this week announced that it will start accepting all non-COVID in vitro diagnostic pre-submissions starting June 1, 2022.
Jun 3, 2022
-
Diagnostics World News | Innovative Practices Award | Extracting high-quality data from clinical records can be time-consuming and costly, primarily when manual abstractors are tasked with mining complex, unstructured, and lengthy documents. That’s why the scientists at Guardant Health and Linguamatics, an IQVIA company, launched a real-world evidence database called GuardantINFORM. The platform was named one of the 2022 Bio-IT World Innovative Practices award winners.
Jun 2, 2022
-
Diagnostics World News | Crosscope and Farcast Bioscience created OrionAI–an artificially intelligent (AI) diagnostic assistant for tumor histological examination. Crosscope developed the AI-enabled digital pathology platform and proprietary algorithms, while Farscape Bioscience created the histoculture platform that preserves entire human tumor microenvironments. OrionAI increases diagnostic speed and lowers misdiagnosis rates of head and neck squamous cell carcinoma, a highly prevalent disease worldwide.
May 31, 2022
-
Diagnostics World | This week Illumina announced the addition of a companion diagnostic (CDx) indication to its CE-marked in vitro diagnostic TruSight Oncology (TSO) Comprehensive (EU) test. This single test kit, recently launched across Europe, assesses multiple tumor genes and biomarkers to reveal the specific molecular profile of a patient's cancer.
May 27, 2022
-
Diagnostics World News | An AI-based diagnostic histoculture platform preserves human tumor microenvironment; FUJIFILM partners with over 150 imaging centers across the United States; two multiplex respiratory virus tests enable rapid differentiation and detection; and more.
May 26, 2022
-
Diagnostics World News| Funding for pathology diagnostics, rapid DNA sequencing, AI-powered disease detection, and more.
May 25, 2022
-
Diagnostics World News | Electrical and computer engineers at Stevens Institute of Technology, together with clinical dermatology specialists at Hackensack University Medical Center (HUMC), are collaboratively developing a low-cost, handheld imaging device that provides laboratory-grade diagnoses of different types of skin cancer. It should be received as a welcome alternative to skin biopsies, about half of which are unnecessarily done for want of another method for differentiating benign from cancerous tissue.
May 19, 2022
-
Diagnostics World News | Stephen Kingsmore, Rady Children’s Institute for Genomic Medicine, and Stavros Papadopoulos, TileDB, presented at Bio-IT World Conference & Expo about diagnostic whole-genome testing, newborn screening, treatment integration, and a single-platform multi-dimensional database.
May 18, 2022
-
Diagnostics World News| A first-of-its-kind microfluidic diagnostic device that eliminates the usual liquid handling steps could enable pathogen detection, as well as gene sequencing, outside of a lab setting involving a lot of equipment and personnel. The small, no-frills chip is being developed by electrical and computer engineers at the University of Minnesota Twin Cities.
May 17, 2022
-
Diagnostics World | A pioneering program of Geisinger Health System has returned clinically actionable results from exome sequencing to a record-breaking 3,400 individuals at increased risk for potentially life-threatening conditions such as hereditary breast and colon cancers, familial hypercholesterolemia (FH), and heart disease. The MyCode Community Health Initiative, enabled by a 2014 agreement with Regeneron Pharmaceuticals, draws from participants in a sizable DNA biobank who agree to the sequencing and results reporting.
May 11, 2022
-
Diagnostics World News | An interdisciplinary team of researchers at The Ohio State University (OSU) is creating a “new paradigm for personalized medicine” with a skin gas sensing device for monitoring metabolism and managing weight.
May 5, 2022
-
Diagnostics World News | Over the next few years, pharmacogenomics could start to become a standard component of clinical care to improve drug efficacy and avoid adverse responses when certain medicines are prescribed.
May 3, 2022
-
Diagnostics World | Funding for AI in disease detection and non-invasive brain diagnostics, immune-oncology cancer therapeutics, tissue therapeutics, and more.
Apr 29, 2022
-
Diagnostics World News | New genomics efforts in Brazil, HPV variant tests, COVID-19 virus and antibody tests, pre-term birth prediction by RNA profiling, metabolomics-based diagnostics, high-plex spatial imaging, blood-based glycoproteomics, new device for detecting mild cognitive impairment, and an award for rapid infection diagnostics.
Apr 28, 2022
-
Diagnostics World | Researchers in Australia played a leading role in development of a DNA-based test to catch what short-read Illumina sequencing often misses: long and repetitive genetic variants implicated in about 40 late-onset neurodegenerative and neuromuscular conditions. These highly complex short tandem repeat (STR) expansion disorders, which have proven difficult to profile with any technology, can now be handily diagnosed with Oxford Nanopore Technology (ONT).
Apr 26, 2022
-
Diagnostics World | At the height of the Omicron surge this winter, at-home rapid tests and PCR testing were hard to come by for everyone, but especially people with low-incomes, non-native English speakers, and immigrant communities. Along with more eligible people being vaccinated, an affordable, accessible NAAT test for the masses is the most effective way to live with the virus rather than being dominated by it again.
Apr 22, 2022
-
Diagnostics World | A Stanford team led by Euan Ashley, professor of medicine, genetics and biomedical data science, sequenced a patient’s genome in a snappy five hours and two minutes on a PromethION platform from Oxford Nanopore, an achievement ratified by the Genome in a Bottle Consortium of the National Institute of Science and Technology.
Apr 20, 2022
-
Diagnostics World | A blood test to help clinicians diagnose Alzheimer’s disease is “on the road” to effectively replacing cerebrospinal fluid (CSF) testing and PET scans for detecting Alzheimer’s pathology, according to Randall J. Bateman, M.D., a professor of neurology at Washington University School of Medicine and co-developer of the plasma protein assay. A commercial version of the test, PrecivityAD, is already being used extensively in clinical trials as well to evaluate patients in real-world settings.
Apr 19, 2022
-
Diagnostics World News | Coagulation factor proteins in the blood might be incorporated into standard blood tests to rapidly detect sepsis soon after infection but before disease symptoms such as excessive inflammation and blood clotting have happened, suggests a research initiative that markedly increased the survival of mice.
Apr 14, 2022